Alicia Goodman
Human Resources Officer bij CERUS CORPORATION
Profiel
Alicia Goodman is currently the Chief Human Resources Officer at Cerus Corp.
Prior to this, she was the Senior Vice President of Human Resources at Aimmune Therapeutics, Inc. from 2019 to 2023.
She also served as the Vice President of Human Resources at Novartis AG and the Senior VP, Chief People & Culture Officer at Berg LLC.
Ms. Goodman received her undergraduate degree from Michigan State University and her graduate degree from Central Michigan University.
Actieve functies van Alicia Goodman
| Bedrijven | Functie | Begin |
|---|---|---|
| CERUS CORPORATION | Human Resources Officer | 27-09-2023 |
Eerdere bekende functies van Alicia Goodman
| Bedrijven | Functie | Einde |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Human Resources Officer | 01-02-2023 |
| NOVARTIS AG | Human Resources Officer | - |
Berg LLC
 Berg LLC Pharmaceuticals: MajorHealth Technology Berg LLC operates as a biopharmaceutical company, which focuses on taking a bold back to biology approach to therapeutic discovery using its Interrogative Biology platform. Its therapeutics include cancer metabolism and BPM 31510, chemotherapy induced alopecia and BPM 315453, neurology-discovery program, and metabolic disease-discovery program. The company was founded by Carl Edwin Berg, Mitch Gray, and Niven R. Narain in 2006 and is headquartered in Framingham, MA. | Human Resources Officer | - |
Opleiding van Alicia Goodman
| Central Michigan University | Graduate Degree |
| Michigan State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| NOVARTIS AG | Health Technology |
| CERUS CORPORATION | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
Berg LLC
Berg LLC Pharmaceuticals: MajorHealth Technology Berg LLC operates as a biopharmaceutical company, which focuses on taking a bold back to biology approach to therapeutic discovery using its Interrogative Biology platform. Its therapeutics include cancer metabolism and BPM 31510, chemotherapy induced alopecia and BPM 315453, neurology-discovery program, and metabolic disease-discovery program. The company was founded by Carl Edwin Berg, Mitch Gray, and Niven R. Narain in 2006 and is headquartered in Framingham, MA. | Health Technology |
